Radiation Dose in Cancer Radiotherapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 October 2024) | Viewed by 4324
Special Issue Editor
Interests: radiation dosimetry; radiation detectors; radiotherapy treatment planning; radiotherapy technological developments
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
More than half of cancer patients receive radiotherapy as part of their treatment and ongoing developments in the field have ensured that radiotherapy remains a key treatment option. Technological developments have seen the implementation of image guided, high precision treatments such as stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR) employing high dose, low fraction treatment regimens. The number of proton and carbon beam therapy facilities continues to rise globally and developments in molecular radiotherapy and brachytherapy have also been seen. Synergistic approaches using biological and immunotherapy agents are also being developed. These approaches have been supported by developments in preclinical investigations in small animal imaging and irradiation (SARP). All of these developments require accurate determination of the radiation dose to ensure clinical outcomes are not compromised. The aim of this special issue is to provide an up to date overview of developments in all aspects of Radiation Dose in Cancer Radiotherapy.
Prof. Dr. Andrew Nisbet
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiation dosimetry
- radiation detectors
- radiotherapy treatment planning
- radiotherapy technological developments
- cancer patients
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.